OrbiMed’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
OrbiMed's JAZZ Position: Q3 2026 in Review
OrbiMed opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 131,100 shares worth $30.4M. The stake represents 0.55% of the portfolio and ranks #44 among its holdings. This is a return to the name: OrbiMed previously reported a position in JAZZ as recently as Q3 2018.
OrbiMed first reported a position in JAZZ in Q2 2013 and has held it in 23 quarters since. The position peaked at $179M in Q2 2018. 672 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.
- OrbiMed held 131,100 shares of Jazz Pharmaceuticals worth $30.4M as of Q3 2026.
- Jazz Pharmaceuticals was a new OrbiMed position in Q3 2026.
- Jazz Pharmaceuticals made up 0.55% of OrbiMed's portfolio in Q3 2026, its #44 holding.
- OrbiMed first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 23 quarters since.
- OrbiMed's Jazz Pharmaceuticals position peaked at $179M in Q2 2018.
- 672 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.